■终末期肾病患者的健康管理是一个复杂的过程,移动健康管理技术为终末期肾病患者的健康管理提供了新的选择。对终末期肾病患者移动健康管理的临床研究范围进行了综述,并发现有关移动健康管理的文献中存在的问题,为后续移动健康管理研究提供思路。
■数据库WebofScience,PubMed,科克伦图书馆,Embase,CNKI,万方数据,BMJ,在接受肾脏替代治疗的成人和青少年患者或儿童中,系统地搜索了VIP和VIP,以进行移动健康管理的研究。搜索涵盖了从数据库开始到2023年6月20日的时期。两名独立的审稿人进行了文献筛选过程。在资格筛选之后,共纳入38篇论文进行数据提取和描述性分析.
■最终纳入了来自14个国家的38项研究。其中大多数是介入试验。这些研究中使用的平台包括远程监控系统,应用程序,网站,手机或平板电脑,和社交平台。这些平台为患者提供了广泛的服务,包括疾病管理,行为干预,社会支持,和后续护理。大多数研究集中在患者的临床指标,患者体验,生活质量,和医疗费用。
■我们发现移动健康管理已广泛应用于终末期肾病患者的疾病管理,具有丰富的管理内容和众多的评价指标。未来的研究应加强对患者心理健康的评估,生活质量,和医疗费用。此外,开发临床决策支持系统将使移动健康管理在终末期肾病患者中发挥更有效的作用.
UNASSIGNED: The health management of end-stage renal disease patients is a complicated process, and mobile health management technology provides a new choice for the health management of end-stage renal disease patients. The scope of clinical studies on mobile health management for patients with end-stage renal disease was reviewed, and found that about mobile health management problems existing in the literature were identified to provide ideas for subsequent mobile health management research.
UNASSIGNED: The databases Web of Science, PubMed, The Cochrane Library, Embase, CNKI, Wan Fang Data, BMJ, and VIP were systematically searched for studies on Mobile health management among end-stage renal disease in adult and adolescent patients or children undergoing kidney replacement therapy. The search covered the period from the inception of the databases to June 20, 2023. Two independent reviewers conducted the literature screening process. Following eligibility screening, a total of 38 papers were included for data extraction and descriptive analysis.
UNASSIGNED: A total of 38 studies from 14 countries were finally included. The majority of which were interventional trials. The platforms used in these studies included remote monitoring systems, apps, websites, mobile phones or tablets, and social platforms. These platforms provided patients with a wide range of services, including disease management, behavioral intervention, social support, and follow-up care. Most studies focused on patient clinical indicators, patient experience, quality of life, and healthcare costs.
UNASSIGNED: Our findings that mobile health management has been widely used in disease management of end-stage renal disease patients, with rich management content and many evaluation indicators. Future studies should strengthen the evaluation of patients\' mental health, quality of life, and healthcare costs. Additionally, developing a clinical decision support system would enable mobile health management to play a more effective role in end-stage renal disease patients.